ID: ALA5176149

Max Phase: Preclinical

Molecular Formula: C4H6N4

Molecular Weight: 110.12

Associated Items:

Representations

Canonical SMILES:  NNc1cccnn1

Standard InChI:  InChI=1S/C4H6N4/c5-7-4-2-1-3-6-8-4/h1-3H,5H2,(H,7,8)

Standard InChI Key:  YTRGNBTVTHPFJM-UHFFFAOYSA-N

Associated Targets(Human)

Aspartate aminotransferase, cytoplasmic 118 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 110.12Molecular Weight (Monoisotopic): 110.0592AlogP: -0.24#Rotatable Bonds: 1
Polar Surface Area: 63.83Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.33CX LogP: -0.24CX LogD: -1.22
Aromatic Rings: 1Heavy Atoms: 8QED Weighted: 0.39Np Likeness Score: -2.09

References

1. Wu Q, Sun Z, Chen Z, Liu J, Ding H, Luo C, Wang M, Du D..  (2022)  The discovery of a non-competitive GOT1 inhibitor, hydralazine hydrochloride, via a coupling reaction-based high-throughput screening assay.,  73  [PMID:35820623] [10.1016/j.bmcl.2022.128883]

Source